Abstract:Background Gene therapy applications require safe and efficient methods for gene transfer. Present methods are restricted by low efficiency and short duration of transgene expression. In vivo electroporation, a physical method of gene transfer, has evolved as an efficient method in recent years. We present a protocol involving electroporation combined with a long-acting promoter system for gene transfer to the lung.Methods The study was designed to evaluate electroporation-mediated gene transfer to the lung and to analyze a promoter system that allows prolonged transgene expression. A volume of 250 mu l of purified plasmid DNA suspended in water was instilled into the left lung of anesthetized rats, followed by left thoracotomy and electroporation of the exposed left lung. Plasmids pCiKlux and pUblux expressing luciferase under the control of the cytomegalovirus immediate-early promoter/enhancer (CMV-IEPE) or human polyubiquitin c (Ubc) promoter were used. Electroporation conditions were optimized with four pulses (200 V/cm, 20 ms at 1 Hz) using flat plate electrodes. The animals were sacrificed at different time points up to day 40, after gene transfer. Gene expression was detected and quantified by bioluminescent reporter imaging (BLI) and relative light units per milligram of protein (RLU/mg) was measured by luminometer for p.Pyralis luciferase and immunohistochemistry, using an anti-luciferase antibody.Results Gene expression with the CMV-IEPE promoter was highest 24 h after gene transfer (2932 +/- 249.4 relative light units (RLU)/mg of total lung protein) and returned to baseline by day 3 (382 +/- 318 RLU/mg of total lung protein); at day 5 no-expression was detected, whereas gene expression under the Ubc promoter was detected up to day 40 (1989 +/- 710 RLU/mg of total lung protein) with a peak at day 20 (2821 +/- 2092 RLU/mg of total lung protein). Arterial blood gas (PaO2), histological assessment and cytokine measurements showed no significant toxicity neither at day 1 nor at day 40.Conclusions These results provide evidence that in vivo electroporation is a safe and effective tool for non-viral gene delivery to the lungs. If this method is used in combination with a long-acting promoter system, sustained transgene expression can be achieved. Copyright (c) 2006 John Wiley & Sons, Ltd.

Enhanced in Vivo Transgene Expression and Immunogenicity from Plasmid Vectors Following Electrostimulation in Rodents and Primates.

Application of in Vivo Electroporation Technology in Plasmid Mediated Gene Transfer and DNA Vaccination

Effects of in Vivo Electroporation on Reporter Gene Expression and Immune Responses Induced by DNA Vaccination

An Improved Method for Increasing the Efficiency of Gene Transfection and Transduction.

Novel suction-based in vivo cutaneous DNA transfection platform

Research Advances on Increasing the Transduction Efficiency of Recombinant Adeno-associated Viral Vectors

SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12

In vivo gene expression: DNA electrotransfer

Therapeutic Protein Production in Vivo after Electroporation-Assisted Intramuscular Gene Delivery.

In Vivo Electroporation of Minicircle DNA As a Novel Method of Vaccine Delivery to Enhance HIV-1-Specific Immune Responses

Real-time impedance feedback to enhance cutaneous gene electrotransfer in a murine skin model

551. Enhanced Immune Stimulation and Antigen Presentation of i.m. Injected Plasmid DNA Vaccines by Electroporation

Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes

In Vivo Electroporation and Ubiquitin Promoter - A Protocol for Sustained Gene Expression in the Lung

A Novel System for in Vivo Neprilysin Gene Delivery Using a Syringe Electrode

Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques

Impedance spectroscopy as an indicator for successful in vivo electric field mediated gene delivery in a murine model

Enhanced Immune Response Against HIV-1 Induced by a Heterologous DNA Prime-Adenovirus Boost Vaccination Using Mannosylated Polyethyleneimine As DNA Vaccine Adjuvant

Electroporation-mediated HBV DNA vaccination in primate models.

Gene Electrotransfer into Mammalian Cells Using Commercial Cell Culture Inserts with Porous Substrate

Electroporation Enhances Reporter Gene Expression Following Delivery of Naked Plasmid Dna to the Lung